MARKET

SONN

SONN

Sonnet BioTherapeutics Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.130
-0.060
-1.43%
After Hours: 4.120 -0.01 -0.24% 19:52 05/29 EDT
OPEN
4.190
PREV CLOSE
4.190
HIGH
4.190
LOW
3.950
VOLUME
277.25K
TURNOVER
--
52 WEEK HIGH
54.60
52 WEEK LOW
3.810
MARKET CAP
38.00M
P/E (TTM)
-0.0029
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SONN stock price target is 2.500 with a high estimate of 2.500 and a low estimate of 2.500.

EPS

SONN News

More
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday morning, 7 companies hit new 52-week lows.
Benzinga · 3d ago
Sonnet BioTherapeutics Holdings Provides Business and Earnings Update
ACCESSWIRE · 05/18 12:30
Sonnet BioTherapeutics Q1 EPS $(0.05), Sales $5.68M
Sonnet BioTherapeutics (NASDAQ:SONN) reported quarterly losses of $(0.050) per share. The company reported $5.680 million in sales this quarter.
Benzinga · 05/18 11:38
The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 14)
Benzinga · 05/15 11:49
What To Know About The Move In Sonnet BioTherapeutics
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) were down 11% on Wednesday after skyrocketing 56.9% on Tuesday on COVID-19-related news.
Benzinga · 04/15 15:57
Mid-Afternoon Market Update: NASDAQ Surges 4%; NeuroBo Pharmaceuticals Shares Plunge
Toward the end of trading Tuesday, the Dow traded up 2.43% to 23959.78 while the NASDAQ rose 4% to 8,519.79. The S&P also rose, gaining 2.98% to 2843.81.
Benzinga · 04/14 18:35
Mid-Day Market Update: Crude Oil Down 5.5%; New Age Beverages Shares Jump
Midway through trading Tuesday, the Dow traded up 1.82% to 23816.13 while the NASDAQ rose 2.98% to 8,436.29. The S&P also rose, gaining 2.21% to 2,822.76.
Benzinga · 04/14 16:19
Mid-Morning Market Update: Markets Open Higher; JPMorgan Posts Lower Q1 Profit
Following the market opening Tuesday, the Dow traded up 2.7% to 24021.69 while the NASDAQ rose 3.43% to 8,473.43. The S&P also rose, gaining 2.87% to 2,840.94.
Benzinga · 04/14 14:24

Industry

Restaurants & Bars
-0.14%
Hotels & Entertainment Services
-0.05%

Hot Stocks

Symbol
Price
%Change

About SONN

Sonnet Biotherapeutics Holdings Inc, formerly Chanticleer Holdings, Inc., an oncology-focused biotechnology company. The Company is developing targeted biologic drugs with enhanced single or bispecific mechanisms.
More

Webull offers kinds of Sonnet Biotherapeutics Holdings Inc stock information, including NASDAQ:SONN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SONN stock news, and many more online research tools to help you make informed decisions.